Rare diseases
Investigational molecules
Locations
Back to Italy46 clinical trials in Pozzilli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
ItalyStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
ItalyStudy on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults
ItalyStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
ItalyPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
ItalyA Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
ItalyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
ItalyStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
ItalyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
ItalyStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
ItalyStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
ItalyStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Multiple Sclerosis treatments, including studies of new therapies like frexalimab, remibrutinib, and ocrelizumab. Investigations aim to improve treatment efficacy and develop innovative drug delivery methods.
Multiple ongoing trials evaluating both intravenous and subcutaneous administration methods for enhanced patient care.
Clinical research examining new therapeutic approaches for Parkinson's Disease, with particular attention to early-stage interventions and LRRK2-driven variants. Studies focus on novel compounds like NEU-411 and BIIB122.
Emphasis on safety evaluation and efficacy assessment of new therapeutic compounds.
Innovative studies targeting cardiovascular disease and related conditions, including trials of pelacarsen for lipoprotein management and inclisiran for preventing major cardiovascular events.
Focus on reducing cardiovascular events and improving outcomes in high-risk patients.
Research initiatives investigating treatments for sleep disorders and related neurological conditions, with studies evaluating TAK-861 for narcolepsy and new approaches for idiopathic hypersomnia.
Trials focused on improving daily functioning and quality of life for patients.
Studies addressing Alzheimer's Disease psychosis and related conditions, with trials evaluating ACP-204 for symptom management and long-term safety assessments.
Research aimed at developing effective treatments for psychiatric symptoms in neurodegenerative conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
